Kappa opioid agonists enhanced auditory nerve responses while mu and delta agonists had no effect — identifying a specific dynorphin/kappa role in hearing function.
Kappa-specific hearing enhancementOnly kappa opioid agonists (not mu or delta) enhanced auditory nerve compound action potential amplitudes
What the researchers found
Kappa opioid agonists enhanced auditory nerve compound action potential amplitudes. Mu and delta agonists had no effect. Naloxone altered baseline responses.
Why it matters
This study identifies a specific opioid receptor type (kappa/dynorphin) in hearing function. This could be relevant to understanding hearing loss, tinnitus, and opioid drug side effects on hearing.
How the study worked
Chinchillas received intravenous opioid agonists and antagonists. Click-evoked compound action potentials (N1 and N2) were recorded at the round window of the cochlea.
What this study cannot tell us
Animal study in chinchillas. Intravenous drug administration affects the whole body, not just the ear. The specific site of action (cochlear vs. central) is not definitively established.
How to read the evidence
Preliminary animal study in chinchillas. Systemic drug administration makes the specific site of action uncertain.
When this study was published
Published in 1991. Opioid involvement in auditory function has been further studied.
The bigger picture
Identifying opioid receptor subtypes in hearing could explain hearing-related side effects of opioid medications and open avenues for treating hearing loss or tinnitus.
Questions still open
- Do opioid medications affect hearing through kappa receptors?
- Could kappa agonists treat certain types of hearing loss?
Common questions
Can opioid drugs affect hearing?
Why chinchillas?
Read the original research
Effects of opioid be drugs on auditory evoked potentials suggest a role of lateral olivocochlear dynorphins in auditory function.
Hearing research, 55(1), 133-42
Citation
Sahley, T L; Kalish, R B; Musiek, F E; Hoffman, D W. (1991). Effects of opioid be drugs on auditory evoked potentials suggest a role of lateral olivocochlear dynorphins in auditory function.. Hearing research, 55(1), 133-42.